Systemic Creative is partnering with the Biomedical Physics Group at Lancaster University to produce a groundbreaking prototype wearable device to provide early diagnosis of dementia, Huntington’s and other neurodegenerative diseases, along with neurophysical diagnosis of autism spectrum disorder and other neurocognitive conditions. This device has the potential to radicalise global health diagnostic techniques and dramatically reduce health inequalities.

Based on a functional methodology uniquely developed at Lancaster University by Prof Aneta Stefanovska and her research group, the device will be the first with high-accuracy non-invasive diagnostic capability usable by a non-specialist operator. It will replace MRI for these functions at less than 4% of its lifetime cost and will bring significant additional savings for clinical operators. The wearable cap format will be particularly beneficial to those with ASD and ADHD, for whom it may also provide anxiety-reducing feedback, and improve independence and dignity for those who struggle with MRI and CT scanning.

The production device will fit into the huge, continually growing medical device market offering multiple ways to generate value, suitability for different markets and global sales potential. It presents a high-yielding investment opportunity with potentially double- or triple- digit return, and contains a number of additional income pathways from the research and development process to offset risk. Perhaps most importantly, it represents an opportunity to help millions of people to have better lives and reduce suffering and inequality worldwide.

There is opportunity for everyone to get involved, including individuals, EIS or SEIS registered investors, and companies. We can offer enhanced CSR, publicity and affiliation with cutting edge biophysics research with a globally renowned academic group and university. 

The theoretical basis upon which the prototype will work is proven and backed by decades of research and publications. The group has global collaborators including Sony Corporation, University Medical Centre Ljubljana, and Brain Hero, and are considered world leaders in the understanding of the non-linear dynamics of living systems. The combination of their state-of-the-art biophysical theory with recently developed wearable sensor hardware will produce a device with proprietary diagnostic algorithms and multiple patent potential.

In short, we want to radically improve the diagnosis and monitoring of neurodegenerative diseases and neurocognitive disorders globally, and we’re seeking visionary investors to help us do it. If you’re one of them, or think you might be, please click the link below to download our full Investor Information Pack or contact Andrew directly on:

andrew.smalley@systemic-creative.co.uk
01706 434001